What is LucenceINSIGHT™?
The importance of early detection
The Singapore Ministry of Health (MOH) estimates that 1 in 4 people are at risk of developing cancer at some point in their lives*. Early testing and detection are critical for improving your chances of survival.
Unfortunately, traditional screenings may not be enough to cover every form of cancer. While doctors can test individually for specific cancers today, more than 70% of cancer deaths are caused by cancers that are not included in standard recommended screening tests.
LucenceINSIGHT™ is a multi-cancer early detection (MCED) next-generation sequencing test that screens for the signals of up to 50 cancers in one simple blood draw, allowing us to detect cancer by capturing both sequence and cell information. By using LucenceINSIGHT™, our healthcare specialists can detect cancer earlier with >99% specificity**, allowing you to receive the care and treatment you need.
*Singapore Cancer Registry Annual Report 2021
**Poh, J. et al. J. Clin. Oncol. 2024; 42(16): e15042.
